<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
<!--    <meta content="width=device-width, initial-scale=1.0" name="viewport">-->
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">

</head>


<body>
<div class="uk-container">
    <p> View in chapter -> <a href="5_treatment_of_current_(active)_disease_therapy__g__antiretroviral_therapy_(art)_and_treatment_of_persons.html/#table16"> Antiretroviral Therapy (ART) and Treatment of Persons Living with HIV and Active TB </a></p>
    <div class="uk-overflow-auto"
         id="table_16_when_to_start_hiv_therapy">
        <table class="uk-table uk-table-small uk-table-divider">
            <thead>
                <tr>
                    <th colspan="2">HHS Panel Recommendations on treatment of Tuberculosis Disease with HIV co-infection: Timing of Antiretroviral Therapy (ART) Initiation relative to TB treatment</th>
                </tr>
            </thead>
            <tr>
                <td>CD4 count and/or clinical status at time of TB diagnosis</td>
                <td>ART Initiation</td>
            </tr>
            <tr>
                <td>< 50 cells/mm3**</td>
                <td>within 2 weeks of starting TB therapy.</td>
            </tr>
            <tr>
                <td>> 50 cells/mm3**</td>
                <td>by 8 to 12 weeks of starting TB therapy</td>
            </tr>
            <tr>
                <td>Pregnant, any CD4 count</td>
                <td>As early as feasible</td>
            </tr>
        </table>
        <p>** EXCEPTION: tuberculous meningitis. To avoid life-threatening CNS immune reconstitution inflammatory
            syndrome (IRIS), persons living with HIV and tuberculous meningitis should not be started on ART until AFTER
            8 weeks of TB therapy</p>
        <p>Above based on guidelines developed by the Department of Health and Human Services (DHHS) Panel on Guidelines
            for Use of Antiretroviral Agents for Adults and Adolescents and Use of Antiretroviral Drugs in Pregnant
            Women with HIV Infection and Interventions to Reduce Perinatal Transmission in the United States, last
            reviewed and updated April 15, 2019 (<a href="https://aidsinfo.nih.gov/guidelines">https://aidsinfo.nih.gov/guidelines</a>).
        </p>

    </div>
</div>
</body>
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
</html>
